Author:
MALIK YASHPAL SINGH,SIRCAR SHUBHANKAR,BHAT SUDIPTA,R VINODHKUMAR O,TIWARI RUCHI,SAH RANJIT,RABAAN ALI A,RODRIGUEZ-MORALES ALFONSO J,DHAMA KULDEEP
Abstract
After the appearance of first cases of ‘pneumonia of unknown origin’ in the Wuhan city, China, during late 2019, the disease progressed fast. Its cause was identified as a novel coronavirus, named provisionally 2019-nCoV. Subsequently, an official name was given as SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) by the International Committee on Taxonomy of Viruses (ICTV) study group. The World Health Organization (WHO) named the Coronavirus disease-2019 as COVID-19. The epidemics of COVID-2019 have been recorded over 113 countries/territories/areas apart from China and filched more than 4,292 humans, affecting severely around 1,18,326 cases in a short span. The status of COVID-2019 emergency revised by the WHO within 42 days from Public Health International Emergency (January 30, 2020) to a pandemic (March 11, 2020). Nonetheless, the case fatality rate (CFR) of the current epidemic is on the rise (between 2–4%), relatively is lower than the previous SARS-CoV (2002/2003) and MERS-CoV (2012) outbreaks. Even though investigations are on its way, the researchers across the globe have assumptions of animal-origin of current SARS-CoV-2. A recent case report provides evidence of mild COVID-2019 infection in a pet dog that acquired COVID-2019 infection from his owner in Hong Kong. The news on travellers associated spread across the globe have also put many countries on alert with the cancellation of tourist visa to all affected countries and postponement of events where international visits were required. A few diagnostic approaches, including quantitative and differential real-time polymerase chain reaction assays, have been recommended for the screening of the individuals at risk. In the absence of any selective vaccine against SARS-CoV-2, re-purposed drugs are advocated in many studies. This article discourse the current worldwide situation of COVID-2019 with information on virus, epidemiology, host, the role of animals, effective diagnosis, therapeutics, preventive and control approaches making people aware on the disease outcomes.
Publisher
Indian Council of Agricultural Research, Directorate of Knowledge Management in Agriculture
Subject
General Veterinary,Animal Science and Zoology
Reference91 articles.
1. Amer H M. 2018. Bovine-like coronaviruses in domestic and wild ruminants. Animal Health Research Reviews 19(2): 113–24.
2. Ayittey F K, Ayittey M K, Chiwero N B, Kamasah J S and Dzuvor C. 2020. Economic impacts of Wuhan 2019 nCoV on China and the world. Journal of Medical Virology 2020: 1–3.
3. Benvenuto D, Giovannetti M, Ciccozzi A, Spoto S, Angeletti S and Ciccozzi M. 2020. The 2019 new coronavirus epidemic: evidence for virus evolution. Journal of Medical Virology 92: 455–59.
4. Binn L, Lazar E, Keenan K, Huxsoll D, Marchwicki R and Strano A. 1974. Recovery and characterization of a coronavirus from military dogs with diarrhea. Proceedings of the Annual meeting of the United States Animal Health Association.
5. Biscayart C, Angeleri P, Lloveras S, Chaves T, Schlagenhauf P and Rodríguez-Morales A J. 2020. The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers?-Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI). Travel Medicine and Infectious Disease 33: 101567.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献